JASON BORILLO: Open Payments
NPI 1427003565 · TEXAS CITY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$561 in 13 payments from 4 companies in 2025. Trend: 2023 $353 · 2024 $89 · 2025 $561
Food & beverage: $561
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 2 | $246 |
| Gilead Sciences, Inc. | 9 | $184 |
| Novo Nordisk Inc | 1 | $109 |
| Organon LLC | 1 | $21 |
Products named: APRETUDE, Ozempic, NEXPLANON.
Industry payments across TX — which companies pay providers there.
